Skip to Main Content

antibiotics

Antibiotics are not terribly profitable, but they are critical to health care. Now, however, the most popular antibiotics are increasingly failing against antibiotic-resistant strains of bacteria, thanks to overuse in both humans and agriculture. STAT’s team of reporters are covering new policy solutions, efforts from pharmaceutical companies, health care worker and patient education around antibiotics, and the public health perspective.

Latest

First Opinion Mark H. Smith

The FDA needs to embrace phage therapy to help fight antimicrobial resistance

Health Annalisa Merelli

CDC endorses prophylactic antibiotics to reduce STIs in high-risk groups

First Opinion Henry Skinner

Antibiotic innovation is ailing. ‘Brain drain’ may kill it

The Readout Meghana Keshavan

STAT Plus: Novo Nordisk’s growth plan

Pharmalot Ed Silverman

STAT Plus: New antibiotics were underprescribed for hard-to-treat infections, study finds

Health tech Katie Palmer

STAT Plus: Telehealth providers can drive antibiotic overuse — or choose to combat it

Pharmalot Ed Silverman

STAT Plus: Chick-fil-A drops a ‘No Antibiotic Ever’ pledge on chicken over supply issues

Health Deborah Balthazar

Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance

All Coverage

First Opinion Manica Balasegaram

Gaza, Ukraine, and other conflicts could be accelerating antibiotic resistance

Pharmalot Ed Silverman

STAT Plus: Amid fears of superbugs, sales of antibiotics used in food-producing livestock rose last year

advertisement

Pharmalot Ed Silverman

STAT Plus: Sales of antibiotics for food-producing animals dropped by more than half in Europe over the past decade

Pharmalot Ed Silverman

STAT Plus: FDA cites cancer links in seeking to withdraw approval of antibiotic used in pigs

Health Helen Branswell

New antibiotic targets gonorrhea as well as last existing treatment, study shows

The Readout Damian Garde

STAT Plus: The XBI biotech index hit its lowest point since 2018. No one knows what comes next.

In the Lab Jason Mast

Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics

First Opinion Brian Finrow

STAT Plus: Preventive drugs may be the best solution to the antibiotic resistance crisis

Health Helen Branswell

CDC proposes new antibiotics policy aimed at reducing STIs

Health Simar Bajaj

STAT Plus: Superbugs, antibiotic resistance get renewed scrutiny in Congress

Pharmalot Ed Silverman

STAT Plus: Pharma’s ambitious antibiotic venture fund makes another investment

Pharmalot Ed Silverman

STAT Plus: McDonald’s adds targets for limiting antibiotic use in beef to its menu, but doesn’t say when

Pharmalot Ed Silverman

STAT Plus: Amid fears of superbugs, sales of antibiotics used in food-producing livestock barely declined last year

First Opinion Carlos del Rio

Congress: Confront the superbug crisis and pass PASTEUR

Pharmalot Ed Silverman

STAT Plus: Sales of antibiotics for food-producing animals dropped by nearly half in Europe over the past decade

Pharmalot Ed Silverman

STAT Plus: Several big U.S. grocery chains are failing to stop antibiotic overuse in their meat supply chains

First Opinion Steven Roach

FDA and USDA need to get on board with the CDC about reducing antibiotic use in raising animals for food

Pharmalot Ed Silverman

STAT Plus: ‘Eye-opening’: The Covid-19 pandemic accelerated antimicrobial resistance across the U.S.

Pharmalot Ed Silverman

STAT Plus: In a first-of-its-kind deal, major drugmaker licenses antibiotic production for low-income countries

First Opinion Harry Rhodes

FDA needs to follow through on its plan to ban carbadox in animal feed

Pharmalot Ed Silverman

STAT Plus: U.K. readies a Netflix-style subscription payment model for badly needed antibiotics